Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies
暂无分享,去创建一个
J. Rader | J. Schellens | P. Fracasso | C. Slapak | L. Goldstein | D. D. de Alwis | V. André | S. A. Goodner | C. L. Fears | M. Arquette | Michael F. Burgess | L. Wright | R. Gazak | Lisa P. Wright